blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3972616

EP3972616 - COMPOSITION AND METHOD FOR INHIBITING AMYLOID BETA ACCUMULATION AND/OR AGGREGATION [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  25.02.2022
Database last updated on 25.09.2024
FormerThe international publication has been made
Status updated on  13.06.2020
Most recent event   Tooltip03.01.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Innopeutics Corporation
510 ho, (Seongsu-dong 2-ga, HausD Sejong Tower)
26, Seongsuil-ro 10-gil
Seongdong-gu
Seoul 04793 / KR
[2022/13]
Inventor(s)01 / LEE, Sang Hun
121-1502, 82, Haengdang-ro, Seongdong-gu
Seoul 04717 / KR
02 / SONG, Jae Jin
18, Bangullae-ro 7-gil, Mapo-gu
Seoul 03961 / KR
03 / YANG, Yun Seon
Rm 1119, 1022, Tongil-ro, Eunpyeong-gu
Seoul 03311 / KR
04 / KIM, Tae Gyun
103-1302, 16, Teheran-ro 52-gil, Gangnam-gu
Seoul 06213 / KR
 [2022/13]
Representative(s)Plougmann Vingtoft a/s
Strandvejen 70
2900 Hellerup / DK
[2022/13]
Application number, filing date20730538.412.03.2020
[2022/13]
WO2020KR03439
Priority number, dateKR2019006088323.05.2019         Original published format: KR 20190060883
KR2020000686117.01.2020         Original published format: KR 20200006861
[2022/13]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2020117031
Date:11.06.2020
Language:EN
[2020/24]
Type: A2 Application without search report 
No.:EP3972616
Date:30.03.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 11.06.2020 takes the place of the publication of the European patent application.
[2022/13]
Search report(s)International search report - published on:KR30.07.2020
(Supplementary) European search report - dispatched on:EP13.06.2022
ClassificationIPC:A61K38/17, A61K35/30, A61K31/7088, A61P25/28, A61K31/7105, A61K48/00, C07K14/47, C12N15/86
[2022/28]
CPC:
A61K31/7105 (EP); A61K48/00 (KR); C07K14/70567 (US);
A61K35/30 (EP,KR); A61K38/177 (EP); A61K48/005 (EP,US);
A61P25/28 (EP,KR,US); C07K14/47 (US); C07K14/4702 (EP);
C07K14/4711 (EP); C12N15/86 (EP,US); A61K38/00 (US);
A61K9/0019 (US); A61K9/0085 (US); C12N2740/16044 (EP);
C12N2750/14143 (EP) (-)
Former IPC [2022/13]A61K35/30, A61K31/7088, A61P25/28
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/13]
TitleGerman:ZUSAMMENSETZUNG UND VERFAHREN ZUR HEMMUNG DER AMYLOID-BETA-SAMMLUNG UND/ODER -AGGREGATION[2022/13]
English:COMPOSITION AND METHOD FOR INHIBITING AMYLOID BETA ACCUMULATION AND/OR AGGREGATION[2022/13]
French:COMPOSITION ET MÉTHODE D'INHIBITION DE L'ACCUMULATION ET/OU DE L'AGRÉGATION DE BÊTA-AMYLOÏDES[2022/13]
Entry into regional phase08.09.2021National basic fee paid 
08.09.2021Search fee paid 
08.09.2021Designation fee(s) paid 
08.09.2021Examination fee paid 
Examination procedure08.09.2021Examination requested  [2022/13]
11.11.2022Amendment by applicant (claims and/or description)
Fees paidRenewal fee
17.01.2022Renewal fee patent year 03
05.01.2023Renewal fee patent year 04
03.01.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]  - "Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease", EMBO MOLECULAR MEDICINE, US, vol. 7, no. 5, doi:10.15252/emmm.201404610, ISSN 1757-4676, (20150501), pages 510 - 525, URL: https://onlinelibrary.wiley.com/doi/full-xml/10.15252/emmm.201404610, XP055786266 [Y] 1-5 * abstract * * page 510, column l, paragraph 1 - page 523, column l, paragraph 4 *

DOI:   http://dx.doi.org/10.15252/emmm.201404610
 [Y]  - SONG JAE-JIN ET AL, "Cografting astrocytes improves cell therapeutic outcomes in a Parkinson's disease model", THE JOURNAL OF CLINICAL INVESTIGATION, GB, vol. 128, no. 1, doi:10.1172/JCI93924, ISSN 0021-9738, (20171211), pages 463 - 482, URL: https://www.jci.org/articles/view/93924/version/4/pdf/render.pdf, XP055923558 [Y] 1-5 * abstract * * page 463, column l, paragraph 1 - page 480, column r, paragraph 2 *

DOI:   http://dx.doi.org/10.1172/JCI93924
 [Y]  - BRONZUOLI MARIA ROSANNA ET AL, "Targeting neuroinflammation in Alzheimer's disease", JOURNAL OF INFLAMMATION RESEARCH, Volume 9, doi:10.2147/JIR.S86958, (20161103), pages 199 - 208, URL: https://www.dovepress.com/getfile.php?fileID=33385, XP055923560 [Y] 1-5 * abstract * * page 199, paragraph 1 - page 205, column l, paragraph 3 *

DOI:   http://dx.doi.org/10.2147/JIR.S86958
 [Y]  - MOON MINHO ET AL, "Nurr1 (NR4A2) regulates Alzheimer?s disease-related pathogenesis and cognitive function in the 5XFAD mouse model", AGING CELL, GB, vol. 18, no. 1, doi:10.1111/acel.12866, ISSN 1474-9718, (20181204), pages 1 - 11, URL: https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Facel.12866, XP055786262 [Y] 1-5 * abstract * * page 2, column l, paragraph 1 - page 9, column r, paragraph 3 *

DOI:   http://dx.doi.org/10.1111/acel.12866
International search[A]KR20120003098  (IUCF HYU [KR]) [A] 1-21;
 [X]US2017354688  (LEE SANG-HUN [KR], et al) [X] 1-21;
 [A]WO2018185260  (HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM GESUNDHEIT & UMWELT GMBH [DE]) [A] 1-21;
 [A]US2018339000  (KERN RUSSELL A [US], et al) [A] 1-21;
 [A]KR20190051837  (IUCF HYU [KR])[A] 1-21
by applicant   - SAURA J, "Microglia in astroglial cultures: a cautionary note", J Neuroinflammation, (20070000), vol. 4, page 26, XP021037913
    - HEINRICH CGASCON SMASSERDOTTI GLEPIER ASANCHEZ RSIMON-EBERT TSCHROEDER TGOTZ MBERNINGER B, "Generation of subtype-specific neurons from postnatal astroglia of the mouse cerebral cortex", Nat Protoc, (20110000), vol. 6, pages 214 - 228
    - BLASI EBARLUZZI RBOCCHINI VMAZZOLLA RBISTONI F, "Immortalization of murine microglia by a v-raf/v-myc carrying retrovirus", J Neuroimmunol, (19900000), vol. 27, pages 229 - 237
    - YANG, C. N.WU, M. F.LIU, C. C.JUNG, W. H.CHANG, Y. C.LEE, W. P.CHAN, C. C., "Differential protective effects of connective tissue growth factor against Abeta neurotoxicity on neurons and glia", Hum Mol Genet, (20170000), vol. 26, no. 20, pages 3909 - 3921
    - RIES, M.SASTRE, M, "Mechanisms of Abeta Clearance and Degradation by Glia", Front Aging Neurosci, (20160000), vol. 8, page 160
    - CZIRR, E. et al., "Microglial complement receptor 3 regulates brain Abeta levels through secreted proteolytic activity", J Exp Med, (20170000), vol. 214, no. 4, pages 1081 - 1092
    - HONG, S.BEJA-GLASSER, V. F.NFONOYIM, B. M.FROUIN, A.LI, S.RAMAKRISHNAN, S.MERRY K.M.SHI Q.ROSENTHAL A.BARRES B.A., "Complement and microglia mediate early synapse loss in Alzheimer mouse models", Science, (20160000), vol. 352, no. 6286, pages 712 - 716
    - SHI, Q. et al., "Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice", Sci Transl Med, (20170000), vol. 9, no. 392
    - KANG, S. S. et al., "Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau", J Exp Med, (20180000), vol. 215, no. 9, pages 2235 - 2245
    - VENEGAS, C. et al., "Microglia-derived ASC specks cross-seed amyloid-beta in Alzheimer's disease", Nature, (20170000), vol. 552, no. 7685, doi:10.1038/nature25158, pages 355 - 361, XP055473472

DOI:   http://dx.doi.org/10.1038/nature25158
    - HENEKA, M. T. et al., "NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice", Nature, (20130000), vol. 493, no. 7434, doi:10.1038/nature11729, pages 674 - 678, XP055125448

DOI:   http://dx.doi.org/10.1038/nature11729
    - BUSSIAN, T. J. et al., "Clearance of senescent glia prevents tau-dependent pathology and cognitive decline", Nature, (20180000), vol. 562, no. 7728, pages 578 - 582
    - CHINTA, S. J. et al., "Cellular Senescence Is Induced by the Environmental Neurotoxin Paraquat and Contributes to Neuropathology Linked to Parkinson's Disease", Cell Rep, (20180000), vol. 22, no. 4, pages 930 - 940
    - BHAT, R. et al., "Astrocyte senescence as a component of Alzheimer's disease", PLoS One, (20120000), vol. 7, no. 9, page e45069
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.